KorrekturOpen Access · CC BY 4.0
Correction to “Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application”
Chronic Diseases and Translational Medicine · 21.08.2026
DOI: 10.1002/cdt3.70063 ↗Kurz gefasst
Korrektur in der Zeitschrift Chronic Diseases and Translational Medicine, online erschienen am 21.08.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
[This corrects the article DOI: 10.1002/cdt3.155.].
Zitieren
APA
(2026). Correction to “Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application”. Chronic Diseases and Translational Medicine. https://doi.org/10.1002/cdt3.70063
Vancouver
Correction to “Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application”. Chronic Diseases and Translational Medicine. 2026. doi:10.1002/cdt3.70063
BibTeX
@article{euvimed2026,
title = {Correction to “Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application”},
journal = {Chronic Diseases and Translational Medicine},
year = {2026},
doi = {10.1002/cdt3.70063}
}
EUVIMED